Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along…mehr
Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.
Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy.
Mahfoozur Rahman is an Assistant Professor at the Department of Pharmaceutical Sciences, Faculty of Health Science, Sam Higginbottom University of Agriculture, Technology & Sciences (SHUATS), Allahabad, India. He has authored more than 130 publications in peer-reviewed journals, 30 book chapters, seven books, and four articles in international magazines with various publishers. He has a Google Scholar h-index of 27 and over 1700 citations to his credit. He also serves on the editorial boards and as guest editor for several journals. He has received travel grants from various international congresses, such as IAPRD, MDS, Nano Today, KSN and WCN, on the basis of his research work and contribution in the field.
Inhaltsangabe
1. Cancer vaccines: Past, present and future 2. Inorganic Nanoparticulate Carriers in management of Cancer: Theranostic and Toxicity Apprehension 3. Recent developments in cancer vaccines: Where are we? 4. Application of Nanotechnology assisted devices in cancer treatment 5. Protein Based Nanocarriers as a Potent Drug Delivery Vehicle for Cancer Therapy 6. Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy 7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies 8. Peptide based anticancer targeted therapeutics: State of the Art 9. Polyplexes-based delivery systems for cancer vaccine delivery 10. Lipopolyplexes-based delivery system for cancer vaccine delivery 11. Inorganic nanoparticulate carriers in cancer vaccination 12. Functional nanomaterials and nanocomposites in cancer vaccines 13. DNA vaccines for cancer treatment: Challenges and promises 14. mRNA-based nanovaccines as newer treatment modalities in cancer 15. Cancer immunotherapy: Moving forward with peptide T cell vaccines 16. Product development and scale-up challenges in cancer vaccine development 17. Regulatory landscape in the approval of cancer vaccines 18. Cross-Presentation-based Nanovaccine for Cancer Immunotherapy 19. Immunotherapy based cancer Vaccines: State of the art 20. Therapeutics peptides in Anticancer therapy 21. Inorganic Nanoconjugates For Cancer Theragnosis
1. Cancer vaccines: Past, present and future 2. Inorganic Nanoparticulate Carriers in management of Cancer: Theranostic and Toxicity Apprehension 3. Recent developments in cancer vaccines: Where are we? 4. Application of Nanotechnology assisted devices in cancer treatment 5. Protein Based Nanocarriers as a Potent Drug Delivery Vehicle for Cancer Therapy 6. Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy 7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies 8. Peptide based anticancer targeted therapeutics: State of the Art 9. Polyplexes-based delivery systems for cancer vaccine delivery 10. Lipopolyplexes-based delivery system for cancer vaccine delivery 11. Inorganic nanoparticulate carriers in cancer vaccination 12. Functional nanomaterials and nanocomposites in cancer vaccines 13. DNA vaccines for cancer treatment: Challenges and promises 14. mRNA-based nanovaccines as newer treatment modalities in cancer 15. Cancer immunotherapy: Moving forward with peptide T cell vaccines 16. Product development and scale-up challenges in cancer vaccine development 17. Regulatory landscape in the approval of cancer vaccines 18. Cross-Presentation-based Nanovaccine for Cancer Immunotherapy 19. Immunotherapy based cancer Vaccines: State of the art 20. Therapeutics peptides in Anticancer therapy 21. Inorganic Nanoconjugates For Cancer Theragnosis
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309